Skip to main content
. 2019 Jul 17;17:688–700. doi: 10.1016/j.omtn.2019.07.003

Figure 1.

Figure 1

Workflow of the Present Study

(A) Statistics of 32 cancers in TCGA. (B) Identification of co-occurring and mutual exclusive interactions across 32 cancer types. (C) Identification of candidate genetic interactions using shRNA, CRISPR screening data, and yeast genetic interaction data. (D) Prediction of biomarkers for cancer cell drug sensitivity and resistance. (E) Prognostic analysis.